Down-regulation of MiR-1294 is related to dismal prognosis of patients with esophageal squamous cell carcinoma through elevating C-MYC expression

Cellular Physiology and Biochemistry

Volumn 36, Issue 1, 2015, Pages 100-110

  Liu, Kai ^a   Li, Liyi ^b   Rusidanmu, Aizemaiti ^c   Wang, Yongqing ^c   Lv, Xiayi ^c  

^a Ningbo Medical Treatment Center Lihuili Hospital   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c Lihuili Hospital   (China)

Author keywords

C MYC; Esophageal squamous cell carcinoma; MicroRNA; Prognosis

Indexed keywords

MICRORNA; MICRORNA 1294; TUMOR MARKER; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN1294 MICRORNA, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN;

ADULT; ARTICLE; BIOLOGICAL FUNCTIONS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXPLORATORY RESEARCH; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MTT ASSAY; ONCOGENE C MYC; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; 3' UNTRANSLATED REGION; AGED; CELL MOTION; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UPREGULATION;

3' UNTRANSLATED REGIONS; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; UP-REGULATION;

EID: 84928724261     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374056     Document Type: Article

References (15)

1. Holmes RS, Vaughan TL: Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007;17:2-9.
2. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ: Microrna dysregulation in gastric cancer: A new player enters the game. Oncogene 2010;29:5761-5771.
3. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA: Micrornas-the micro steering wheel of tumour metastases. Nat Rev Cancer 2009;9:293-302.
4. Shen-Ong GL, Keath EJ, Piccoli SP, Cole MD: Novel myc oncogene rna from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell 1982;31:443-452.
5. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM: Human c-myc onc gene is located on the region of chromosome 8 that is translocated in burkitt lymphoma cells. Proc Natl Acad Sci U S A 1982;79:7824-7827.
6. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P: Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 1982;79:7837-7841.
7. Dalla-Favera R, Wong-Staal F, Gallo RC: Onc gene amplification in promyelocytic leukaemia cell line hl-60 and primary leukaemic cells of the same patient. Nature 1982;299:61-63.
8. Hayward WS, Neel BG, Astrin SM: Activation of a cellular onc gene by promoter insertion in alv-induced lymphoid leukosis. Nature 1981;290:475-480.
9. Takwi AA, Li Y, Becker Buscaglia LE, Zhang J, Choudhury S, Park AK, Liu M, Young KH, Park WY, Martin RC, Li Y: A statin-regulated microrna represses human c-myc expression and function. EMBO Mol Med 2012;4:896-909.
10. Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, Ozturk A, Hicks GG, Hannon GJ, He L: Mir-34 mirnas provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011;13:1353-1360.
11. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M, Zhan X: Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 2001;61:6906-6911.
12. Li Y, Choi PS, Casey SC, Dill DL, Felsher DW: Myc through mir-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. Cancer cell 2014;26:262-272.
13. Jackstadt R, Hermeking H: Micrornas as regulators and mediators of c-myc function. Biochim Biophys Acta 2014;pii: S1874-9399(14)00080-7.
14. Miyawaki Y, Kawachi H, Ooi A, Eishi Y, Kawano T, Inazawa J, Imoto I: Genomic copy-number alterations of myc and fhit genes are associated with survival in esophageal squamous-cell carcinoma. Cancer Sci 2012;103:1558-1566.
15. Wang W, Xue L, Wang P: Prognostic value of beta-catenin, c-myc, and cyclin d1 expressions in patients with esophageal squamous cell carcinoma. Med Oncol 2011;28:163-169.